510(k) Report

510(k) · Cleared

Cleared

ICHOR 7F Embolectomy System (ICH-7F)

K233917510(k) TraditionalCleared Jul 18, 2024219-day reviewClass II21 CFR 870.5150

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Ichor · QEW Peripheral Mechanical Thrombectomy With Aspiration

Cleared on Jul 18, 2024 as substantially equivalent to K182167 (Ichor Vascular, Inc., 2018) after a 219-day review. Its family tree reaches back 2 generations to 2017.

Decided
Jul 18, 2024
Review
219 days
Class
Class II
Product code
QEW
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K171493 (2017). No later device cites it as a predicate yet.

  1. Root · 2 generations backK171493 MegaVac Mechanical Thrombectomy SystemCapture Vascular, Inc. · 2017
  2. 1 generation backK182167 The ICHOR Panacea Vascular Embolectomy Catheter SystemIchor Vascular, Inc. · 2018
  3. This deviceK233917 ICHOR 7F Embolectomy System (ICH-7F)Ichor · 2024
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K171493MegaVac Mechanical Thrombectomy SystemCapture Vascular, Inc.2017—
−1K182167The ICHOR Panacea Vascular Embolectomy Catheter SystemIchor Vascular, Inc.2018—
0 (this device)K233917ICHOR 7F Embolectomy System (ICH-7F)Ichor2024—
FIG. 1 — Lineage of K233917, 2017–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QEW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QEW device

  1. #1 K213402 Triever24, Triever20score 28.6 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K182167The ICHOR Panacea Vascular Embolectomy Catheter System
Summary page 5
…age 2 of 4 D. Predicate Device Names Predicate Device: ICHOR Panacea Vascular Embolectomy Catheter System Predicate #: K182167 Predicate Product Code: QEW E. Device Description Summary The ICHOR 7F Embolectomy System is indicated for the no…
Ichor Vascular, Inc.2018—

Also cleared against K182167: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 7 years and passes through 3 companies; a new generation was cleared every 5.6 years on median.
  • None of the 2 ancestors has a recall.
  • 1 other device also cites its predicate K182167.

How does its category compare?

All QEW devices

QEW Peripheral Mechanical Thrombectomy With Aspiration: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · QEW

14in 2025

2008: 22009: 22012: 12013: 22014: 22015: 42016: 42017: 22018: 142019: 82020: 162021: 112022: 122023: 232024: 142025: 142026 (partial year): 10
2007high 23 (2023) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QEW

58in 2025

2015: 88 days median2016: 63 days median2018: 61 days median2019: 51 days median2020: 105 days median2021: 60 days median2022: 140 days median2023: 102 days median2024: 65 days median2025: 58 days median2026 (partial year): 74 days median
2007high 140 (2022) · low 51 (2019)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QEW

7in 2022

2022: 7, 7 Class I
2007high 7 (2022) · low 0 (2007)2026

Class I (7 since 2007) Class II/III not classified

Adverse event reports per year · QEW

207in 2025

2019: 332020: 1972021: 3222022: 1252023: 1652024: 1622025: 207
2007high 322 (2021) · low 0 (2007)2025

MAUDE reports naming product code QEW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20082—00
20092—00
20100—00
20110—00
20121—00
20132—00
20142—00
201548800
201646300
20172—00
2018146100
2019851033
2020161050197
202111600322
2022121407 (7)125
2023231020165
202414650162
202514580207
202610740—

What is it indicated for?

The ICHOR 7F Embolectomy System is indicated for the non-surgical removal of emboli and thrombi from blood vessels. The device is intended for the peripheral vasculature and is not intended for use in the coronary or neurovasculature.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K233917: ICHOR 7F Embolectomy System (ICH-7F).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K233917

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026